Dyad Launches the Latest Version of ALIS
The latest version of ALIS, a core system, delivers more for MGAs and Wholesalers
ALIS has been meeting the insurance processing needs of MGAs and Wholesalers for more than ten years. Customers are now processing more than 15 billion in bound premium across all lines of business on ALIS. This latest version delivers more functionality and a new modern UI to enhance the user experience, simplified workflows to improve end-user efficiency, and robust new features to boost user productivity. ALIS is now SaaS-enabled for simple onboarding and faster rollouts of new features and versions. It also includes an enhanced API library for easy, efficient integrations. In early September, Jimcor Agencies went live on the latest version.
"We are impressed with what the team at Dyad has done with the latest version of ALIS," said
"We know this latest release of ALIS is a major step forward both in terms of business value as well as technical robustness, and we're very excited Jimcor is now live," said
About Jimcor Agencies
Jimcor Agencies is an independent MGA & wholesale brokerage founded in 1986. Since then, Jimcor has grown to represent a portfolio of over 175 admitted and non-admitted markets between its in-house binding authority and brokerage capabilities. For more information, visit jimcor.com.
About Dyad, Inc.
Dyad delivers software and services that simplify insurance processing and distribution. We have redefined insurance technology by continuously improving our solutions, ensuring our customers can focus on growing and evolving their business, delivering superior customer service, and developing valuable insight into their business. Retail agencies, wholesalers, agency networks, program administrators, MGAs, and carriers benefit from our solutions. For more information about Dyad, go to dyadtech.com.
Media Contact:
VP, Marketing
Dyad, Inc.
860-212-5799
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/dyad-launches-the-latest-version-of-alis-302253810.html
SOURCE Dyad, Inc
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AI-empowered Pipeline-in-a-drug Option: Insilico Medicine Nominates ISM9077, Potential First-in-class Target Y Inhibitor, as Preclinical Candidate (PCC) for Ocular Diseases, Inflammatory Disorders and
- Innovent Announces First Patient Dosed in Pivotal Registrational Study of IBI363/TAK-928 (PD-1/IL-2α-biased Bispecific Fusion Protein) in Combination with Bevacizumab in Late-Line Advanced Colorectal
- EtherPR Enhances Crypto PR Distribution with Broader Blockchain Media Coverage
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share